AstraZeneca : Covid-19 Vaccine Is 92% Effective Against Indian Variant

By Ian Walker

AstraZeneca PLC said Tuesday that its Covid-19 vaccine is 92% effective against hospitalizations of the Delta, or Indian, variant after two shots, without any deaths.

The pharmaceutical giant also said the vaccine is 86% effective in reducing hospitalizations in the Alpha, or Kent, variant with no deaths reported.

Vaccine effectiveness against symptomatic disease was 74% against the Alpha variant and 64% against the Delta variant, AstraZeneca added.

"The data show that the vaccine will continue to have a significant impact around the world given that it continues to account for the overwhelming majority of supplies to India and the Covax facility," Executive Vice President, BioPharmaceuticals R&D Mene Pangalos said.

Write to Ian Walker at [e-mail]

(END) Dow Jones Newswires

06-15-21 0235ET